Skip to main content
. Author manuscript; available in PMC: 2020 Nov 6.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2019 Aug 1;105(2):367–375. doi: 10.1016/j.ijrobp.2019.07.023

Fig. 2.

Fig. 2.

Freedom from systemic therapy (FST) since the start of stereotactic ablative radiotherapy (SAbR). (A) Number of metastases treated in the initial course. (B) M0 versus M1. (C) Bone versus non-bone metastasis.